Results 211 to 220 of about 269,290 (261)
Some of the next articles are maybe not open access.

G-CSF - an anti-inflammatory cytokine-

Shock, 1995
We have previously reported that in various macrophage populations prepared from G-CSF treated rats LPS-inducible TNF release was suppressed. In vitro, LPS induced liver cell death only when hepatocytes were cocultured with liver macrophages.
T. Hartung, H-D. Volk, A. Wendel
openaire   +1 more source

[G-CSF treatment].

Nihon rinsho. Japanese journal of clinical medicine, 2016
In acute phase of ischemic stroke, as neuroprotective and neurogenerative role of granulocyte-colony stimulating factor(G-CSF), anti-apoptotic action, anti-inflammatory and anti-immune effect, and brain protective action against excitatory neurotoxicity have been reported.
Atsushi, Mizuma, Shunya, Takizawa
openaire   +1 more source

G-CSF

Inpharma Weekly, 1994
  +4 more sources

G-CSF: filgrastim, lenograstim and biosimilars

Expert Opinion on Biological Therapy, 2014
The identification, purification and molecular cloning of granulocyte colony-stimulating factor G-CSF in the 1980s; the nonclinical studies in the mid-1980s; and the subsequent development of G-CSF as a therapeutic agent in the late 1980s and 1990s have had a major influence on the treatment of many diseases.
openaire   +2 more sources

[G-CSF in radiochemotherapy].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1997
G-CSF enhances the division, maturation and release of granulocyte precursor cells. The shortening of chemotherapy-induced leukopenia via G-CSF is well documented in literature, with fractionated radiotherapy alone one finds a distinct increase of the granulocyte level.
M, Riepl, R, Fietkau, R, Sauer
openaire   +1 more source

[G-CSF in oncology].

Bulletin du cancer, 2006
Neutropenia and its subsequent infectious complications represent the most common dose-limiting toxicity of cancer chemotherapy. Febrile neutropenia (FN) occurs with common chemotherapy regimens in 25 to 40 % of treatment-naive patients, and its severity depends on the dose intensity of the chemotherapy regimen, the patient's prior history and ...
Frédéric, Viret   +4 more
openaire   +1 more source

The choroid plexus links innate immunity to CSF dysregulation in hydrocephalus

Cell, 2023
Tyrone Despenza   +2 more
exaly  

G-CSF

Inpharma Weekly, 1991
openaire   +2 more sources

GM-CSF: A Double-Edged Sword in Cancer Immunotherapy

Frontiers in Immunology, 2022
Srividya Swaminathan   +2 more
exaly  

G-CSF

1998
Tak W. Mak   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy